United States Pharmaceuticals

Sunshine Biopharma Inc (SBFM)

Track

Track

Sunshine Biopharma Inc has recorded no insider trading activity within the past ninety days. The most recent transactions occurred in early 2024, when CEO Steve N. Slilaty purchased shares. Historical data indicates sporadic buying patterns by executives, with the last recorded movement dating back over six months.
Ticker: SBFM Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Sunshine Biopharma Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Slilaty Steve N. Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
41.17
Quantity 67,457 +43.6%
Value US$1,960,668
Slilaty Steve N. Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
181.84
Quantity 36,679 +12.3%
Value US$2,003,530
1.5
Sebaaly Camille CFO/Secretary Officer
Transaction date
Purchase
Price
175.36
Quantity 13,286 +13.3%
Value US$1,630,268
1.5
Sebaaly Camille CFO/Secretary Officer
Transaction date
Purchase
Price
1.22
Quantity 25,000 +20.9%
Value US$30,500
Slilaty Steve N. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.20
Quantity 253,082 +0.8%
Value US$50,009
Slilaty Steve N. Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
0.10
Quantity 500,000 +inf%
Value US$50,000
Slilaty Steve N. Chief Executive Officer Executive Director Large shareholder
Transaction date
Sale
Price
0.05
Quantity 2,591,500 -7.6%
Value US$129,575
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-05 2024-03-04 B Purchase
Slilaty Steve N.

Chief Executive Officer

Executive Director Large shareholder
67,457 +43.6%
41.17
US$1,960,668 		67,457 +43.6% 41.17 US$1,960,668
2024-02-12 2024-02-08 B Purchase
Slilaty Steve N.

Chief Executive Officer

Executive Director Large shareholder
36,679 +12.3%
181.84
US$2,003,530 		36,679 +12.3% 181.84 US$2,003,530
2022-12-02 2022-11-30 B Purchase
1.5
Sebaaly Camille

CFO/Secretary

Officer
13,286 +13.3%
175.36
US$1,630,268 		13,286 +13.3% 175.36 US$1,630,268
2022-06-06 2022-06-03 B Purchase
1.5
Sebaaly Camille

CFO/Secretary

Officer
25,000 +20.9%
1.22
US$30,500 		25,000 +20.9% 1.22 US$30,500
2016-04-26 2016-04-12 B Purchase
Slilaty Steve N.

Chief Executive Officer

Executive Director
253,082 +0.8%
0.20
US$50,009 		253,082 +0.8% 0.20 US$50,009
2015-06-01 2015-05-27 B Purchase
Slilaty Steve N.

Chief Executive Officer

Executive Director Large shareholder
500,000 +inf%
0.10
US$50,000 		500,000 +inf% 0.10 US$50,000
2012-09-07 2012-09-04 S Sale
Slilaty Steve N.

Chief Executive Officer

Executive Director Large shareholder
2,591,500 -7.6%
0.05
US$129,575 		2,591,500 -7.6% 0.05 US$129,575
Explore more

More insider trading research around Sunshine Biopharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America